The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 06, 2021
Filed:
Jul. 29, 2019
Applicant:
Anavex Life Sciences Corp., New York, NY (US);
Inventors:
Linda Sharon Daintree, Leeds, GB;
Daniel Mark Ledger, Bradford, GB;
Lucy Anne Leonard, Bradford, GB;
Peter York, Bradford, GB;
Assignee:
ANAVEX LIFE SCIENCES CORP., New York, NY (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/341 (2006.01); C07D 307/14 (2006.01); A61P 25/28 (2006.01); B01D 9/00 (2006.01); B01D 11/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/341 (2013.01); A61P 25/28 (2018.01); B01D 9/005 (2013.01); B01D 11/0403 (2013.01); C07D 307/14 (2013.01);
Abstract
Polymorphic forms of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (ANAVEX2-73) and a metabolite of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (ANAVEX2-73) are disclosed and characterized. Compositions and method for treatment of Alzheimer's disease that includes the polymorphic forms and metabolite of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (ANAVEX2-73).